Premium
High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T‐cell acute lymphoblastic leukemia
Author(s) -
Akahane Koshi,
Murakami Yasushi,
Kagami Keiko,
Abe Masako,
Harama Daisuke,
Shinohara Tamao,
Watanabe Atsushi,
Goi Kumiko,
Nishi Rie,
Yamauchi Takahiro,
Kimura Shunsuke,
Takita Junko,
Look A. Thomas,
Minegishi Masayoshi,
Sugita Kanji,
Inukai Takeshi
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2654
Subject(s) - biomarker , lymphoblastic leukemia , medicine , cancer research , oncology , leukemia , immunology , biology , genetics